scholarly article | Q13442814 |
P50 | author | Anne-Sophie Lia | Q89678881 |
François Poumeaud | Q91581266 | ||
Franck Sturtz | Q68917683 | ||
P2093 | author name string | Frédéric Favreau | |
Laurent Magy | |||
Claire Demiot | |||
Federica Miressi | |||
Pierre Antoine Faye | |||
P2860 | cites work | The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis | Q46519289 |
Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey | Q46552214 | ||
Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease | Q46575382 | ||
The effects of calcipotriol on the dendritic morphology of human melanocytes under oxidative stress and a possible mechanism: is it a mitochondrial protector? | Q46785935 | ||
Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair | Q47194743 | ||
Evaluation of two fully automated immunoassay based tests for the measurement of 1α,25-dihydroxyvitamin D in human serum and comparison with LC-MS/MS. | Q47428503 | ||
Vitamin D3 repressed astrocyte activation following lipopolysaccharide stimulation in vitro and in neonatal rats | Q47742910 | ||
Developmental Vitamin D Deficiency Affects Spatial Learning in Wistar Rats | Q47955557 | ||
Expression of CYP2R1 and VDR in human brain pericytes: the neurovascular vitamin D autocrine/paracrine model | Q48301921 | ||
Administration of exogenous 1,25(OH)2D3 normalizes overactivation of the central renin-angiotensin system in 1α(OH)ase knockout mice | Q48380849 | ||
Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. | Q48524232 | ||
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model | Q48765973 | ||
Klotho insufficiency causes decrease of ribosomal RNA gene transcription activity, cytoplasmic RNA and rough ER in the spinal anterior horn cells | Q48925490 | ||
Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. | Q49160989 | ||
Vitamin D receptor: A novel therapeutic target for kidney diseases | Q49985993 | ||
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. | Q50132795 | ||
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation | Q50204077 | ||
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial | Q21203734 | ||
Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial | Q21203743 | ||
High Prevalence of Vitamin D Inadequacy and Implications for Health | Q22305468 | ||
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know | Q22306208 | ||
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 | ||
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain | Q24320314 | ||
Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease | Q24633922 | ||
The Non-Genomic Actions of Vitamin D | Q26767360 | ||
Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease | Q28085715 | ||
Warfarin-induced artery calcification is accelerated by growth and vitamin D | Q28370245 | ||
Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo | Q28480498 | ||
1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro | Q28577606 | ||
Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells | Q28587554 | ||
Vitamins A & D inhibit the growth of mycobacteria in radiometric culture | Q28740534 | ||
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis | Q28744264 | ||
Discovery of novel vitamin D-regulated proteins in INS-1 cells: a proteomic approach | Q28854272 | ||
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services | Q33601267 | ||
The Comparison between Effects of 12 weeks Combined Training and Vitamin D Supplement on Improvement of Sensory-motor Neuropathy in type 2 Diabetic Women | Q33697332 | ||
The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons | Q33847890 | ||
Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. | Q33861626 | ||
1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes | Q33869530 | ||
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis | Q33899901 | ||
Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials | Q33954224 | ||
Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study | Q34033531 | ||
Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes | Q34084564 | ||
Vitamin D: modulator of the immune system. | Q34112707 | ||
Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women | Q34117665 | ||
New clues about vitamin D functions in the nervous system | Q34118382 | ||
Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old | Q34210090 | ||
1,25-Vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway | Q34345326 | ||
Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain | Q34543762 | ||
1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells | Q73442850 | ||
Beyond vitamin status: is there a role for vitamin d in Parkinson disease? | Q84563163 | ||
Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5 | Q85597932 | ||
Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease | Q86366225 | ||
Association of vitamin D and multiple sclerosis in India | Q86451867 | ||
Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress | Q86951470 | ||
Vitamin D receptor signaling enhances locomotive ability in mice | Q87417761 | ||
Breaking down the vitamin D-GFR relationship | Q87440105 | ||
Local low dose curcumin treatment improves functional recovery and remyelination in a rat model of sciatic nerve crush through inhibition of oxidative stress | Q90291782 | ||
Joint association of vitamins D and K status with long-term outcomes in stable kidney transplant recipients | Q91502839 | ||
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. | Q50744694 | ||
Synergistic interactions between vitamin A and vitamin E against lipid peroxidation in phosphatidylcholine liposomes. | Q50752291 | ||
An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects. | Q50935555 | ||
1,25-Dihydroxyvitamin D3 suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation. | Q50974764 | ||
Synergistic effect of low K and D vitamin status on arterial stiffness in a general population. | Q51012894 | ||
A predictive equation to guide vitamin D replacement dose in patients. | Q51069333 | ||
Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients. | Q51263456 | ||
Does vitamin D have any role in the improvement of diabetic peripheral neuropathy in type 1 diabetic patients? | Q51281577 | ||
Health Risks of Hypovitaminosis D: A Review of New Molecular Insights. | Q51737061 | ||
Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma. | Q53154285 | ||
Potential relationship between the canonical Wnt signalling pathway and expression of the vitamin D receptor in alopecia. | Q53290999 | ||
[Vitamin D and neuropathy]. | Q54446615 | ||
Diagnostic value of ultrastructural nerve examination in Charcot-Marie-Tooth disease: two CMT 1B cases with pseudo-recessive inheritance. | Q55043179 | ||
Vitamin D, Hypercalciuria and Kidney Stones. | Q55084280 | ||
1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. | Q55481493 | ||
A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter? | Q58696087 | ||
Two nuclear signalling pathways for vitamin D | Q59098586 | ||
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins | Q62002770 | ||
[Effect of combined vitamin D and E deficiencies on calcium metabolism and bone tissue of the rat] | Q70172795 | ||
Renal calcification in suckling rats after high doses of calcitriol (1,25-dihydroxycholecalciferol) | Q70812312 | ||
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid | Q70908424 | ||
A transgenic rat model of Charcot-Marie-Tooth disease | Q71078153 | ||
The role of endogenous nerve growth factor in human diabetic neuropathy | Q71101919 | ||
The effect of vitamin K and D supplementation on ovariectomy-induced bone loss | Q72988688 | ||
1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1 | Q73167155 | ||
Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults | Q34586247 | ||
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. | Q34621641 | ||
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system | Q34793842 | ||
Serum vitamin D and the risk of Parkinson disease | Q34962536 | ||
Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. | Q34967426 | ||
Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats | Q35135715 | ||
Live longer with vitamin D? | Q35227897 | ||
Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice | Q35349544 | ||
1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation | Q35456452 | ||
Retinoids run rampant: multiple roles during spinal cord and motor neuron development | Q35594826 | ||
Multiple sclerosis and vitamin D: an update | Q35726340 | ||
Hypovitaminosis D-induced pain | Q35924737 | ||
Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity | Q35995939 | ||
Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake | Q36349451 | ||
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation | Q36359425 | ||
Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic Patient | Q36490269 | ||
Neurosteroid hormone vitamin D and its utility in clinical nutrition | Q36672359 | ||
Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort | Q36885414 | ||
Cholecalciferol (vitamin D₃) improves myelination and recovery after nerve injury | Q36892472 | ||
Vitamin D, the renin-angiotensin system, and insulin resistance | Q37056390 | ||
Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone | Q37260870 | ||
Effect of vitamin D supplementation on health status in non-vitamin D deficient people with type 2 diabetes mellitus. | Q37428576 | ||
Progesterone as a neuroprotective factor in traumatic and ischemic brain injury | Q37574428 | ||
Neuroactive steroids: an update of their roles in central and peripheral nervous system. | Q37643002 | ||
Vitamin D biology in heart failure: molecular mechanisms and systematic review. | Q37783312 | ||
Clinical practice. Vitamin D insufficiency | Q37830043 | ||
Drugs in the brain--cellular imaging with receptor microscopic autoradiography | Q37975330 | ||
Renin-angiotensin system, hypertension, and chronic kidney disease: pharmacogenetic implications | Q38053262 | ||
Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells | Q38087463 | ||
Is there an association between diabetic neuropathy and low vitamin D levels? | Q38241745 | ||
Sonic hedgehog signalling pathway: a complex network | Q38247955 | ||
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial | Q38438519 | ||
Vitamin D in the Spectrum of Prediabetes and Cardiovascular Autonomic Dysfunction | Q38646004 | ||
Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy | Q38674146 | ||
Vitamin D deficiency and its role in neurological conditions: A review | Q38729785 | ||
Update on FGF23 and Klotho signaling | Q38834365 | ||
Joint Association of Low Vitamin D and Vitamin K Status With Blood Pressure and Hypertension | Q38843505 | ||
Calcium's role as nuanced modulator of cellular physiology in the brain. | Q38935052 | ||
Epilepsy and vitamin D: a comprehensive review of current knowledge. | Q39042331 | ||
A Sonic hedgehog coreceptor, BOC regulates neuronal differentiation and neurite outgrowth via interaction with ABL and JNK activation | Q39166842 | ||
Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression | Q39254258 | ||
The interfaces between vitamin D, sleep and pain | Q39325152 | ||
A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report | Q39363036 | ||
The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3. | Q39507418 | ||
Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis | Q39578679 | ||
An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons | Q39711608 | ||
Effect of 1alpha,25-dihydroxyvitamin D3 in embryonic hippocampal cells. | Q39825191 | ||
RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects | Q39899583 | ||
Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. | Q40052462 | ||
Vitamin D3 and brain development | Q40652918 | ||
A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study | Q41078226 | ||
1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor | Q41169062 | ||
Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study | Q41531107 | ||
Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study | Q41564412 | ||
IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment | Q41647567 | ||
Molecular mechanism of vitamin D receptor action | Q42466746 | ||
Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus | Q42756634 | ||
Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study | Q43048633 | ||
The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review. | Q43375937 | ||
Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis | Q44399469 | ||
1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. | Q44448707 | ||
Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis | Q44824443 | ||
Vitamin D2 potentiates axon regeneration | Q46263063 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | calcitriol | Q139195 |
peripheral nervous system | Q169953 | ||
P304 | page(s) | 348 | |
P577 | publication date | 2019-04-12 | |
P1433 | published in | Frontiers in Neuroscience | Q2177807 |
P1476 | title | Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System | |
P478 | volume | 13 |
Q91647353 | Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs | cites work | P2860 |
Search more.